Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SRPT

Sarepta

$55.04

0.57 (1.05%)

08:31
11/17/17
11/17
08:31
11/17/17
08:31
Conference/Events
Sarepta to participate in a conference call with JPMorgan »

JPMorgan SMid Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$160.15

3.25 (2.07%)

, AGIO

Agios Pharmaceuticals

$59.63

0.56 (0.95%)

07:14
11/17/17
11/17
07:14
11/17/17
07:14
Conference/Events
Needham to hold a tour »

Biotech Bus Tour travels…

BLUE

bluebird bio

$160.15

3.25 (2.07%)

AGIO

Agios Pharmaceuticals

$59.63

0.56 (0.95%)

SRPT

Sarepta

$55.04

0.57 (1.05%)

SAGE

Sage Therapeutics

$85.67

0.2 (0.23%)

AMAG

Amag Pharmaceuticals

$14.15

-0.05 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

  • 09

    Dec

  • 11

    Dec

  • 14

    Dec

  • 02

    Feb

  • 14

    Feb

  • 15

    Nov

Over a week ago
SRPT

Sarepta

$52.44

-3.41 (-6.11%)

, ANTM

Anthem

$215.02

-1.855 (-0.86%)

10:06
11/09/17
11/09
10:06
11/09/17
10:06
Recommendations
Sarepta, Anthem analyst commentary at Baird »

Anthem significantly…

SRPT

Sarepta

$52.44

-3.41 (-6.11%)

ANTM

Anthem

$215.02

-1.855 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$52.44

-3.41 (-6.11%)

09:59
11/09/17
11/09
09:59
11/09/17
09:59
Hot Stocks
Anthem issues updated medical policy for Sarepta's Exondys 51 »

In a Medical Policy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$18.84

-0.29 (-1.52%)

, CHTR

Charter

$337.90

-5.11 (-1.49%)

09:40
11/09/17
11/09
09:40
11/09/17
09:40
Options
Unusually active option classes on open November 9th »

Unusual total active…

ROKU

Roku

$18.84

-0.29 (-1.52%)

CHTR

Charter

$337.90

-5.11 (-1.49%)

SRPT

Sarepta

$52.44

-3.41 (-6.11%)

KSS

Kohl's

TWLO

Twilio

EBAY

eBay

$37.01

-0.4 (-1.07%)

SQ

Square

M

Macy's

XRT

S&P Retail Index SPDR

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 09

    Nov

  • 15

    Nov

  • 18

    Mar

SRPT

Sarepta

$52.44

-3.41 (-6.11%)

, ANTM

Anthem

09:15
11/09/17
11/09
09:15
11/09/17
09:15
Hot Stocks
Anthem no longer requires walk test to reimburse Sarepta's Exondys 51 »

Anthem (ANTM), in a…

SRPT

Sarepta

$52.44

-3.41 (-6.11%)

ANTM

Anthem

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$55.85

0.33 (0.59%)

16:21
11/07/17
11/07
16:21
11/07/17
16:21
Syndicate
Breaking Syndicate news story on Sarepta »

Sarepta files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SRPT

Sarepta

$55.52

2.06 (3.85%)

08:56
11/07/17
11/07
08:56
11/07/17
08:56
Technical Analysis
Technical View: Sarepta moves up to test 52-week high »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SRPT

Sarepta

$55.52

2.06 (3.85%)

08:51
11/07/17
11/07
08:51
11/07/17
08:51
Hot Stocks
Sarepta announces FDA clearance of IND for PPMO Exon 51 candidate »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SRPT

Sarepta

$53.46

2.42 (4.74%)

08:45
11/06/17
11/06
08:45
11/06/17
08:45
Hot Stocks
Sarepta announces FDA clearance of IND for micro-dystrophin gene therapy program »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.